Status update: August 17, 2010
Number of sites enrolling: 10 |
|
| Studies using samples (see details) |
| Studies complete: | 6 (BWH, OMRF, St. John's [data], SUNY[B.Kalman], Vanderbilt,
Wellcome Trust) |
| Studies ongoing: | 28 (BIDMC, BWH, Diogenix[2], Glycominds, HSPH,
JHU[2:Birnbaum, Levy], Mayo Clinic, Montreal Neurological
Institute, MSDx[2], NASA, Pfizer, Protagen, Science Commons
[data], Scripps Research Institute, St. Vincent's Hospital,
Stanford[2: Barres, Butte], SUNY[Massa], UCI, UCSF,
UMaryland[data], UTSW[3: Stuve, Greenberg[data(2)]],
Vanderbilt) |
| Studies approved: | 2 |
| Studies pending: | 0 |
|
